Ethics and statistics in randomized clinical trials. With comments and a rejoinder by the author
From MaRDI portal
Publication:1596041
DOI10.1214/ss/1177011934zbMath0955.62641OpenAlexW1985559178WikidataQ52458885 ScholiaQ52458885MaRDI QIDQ1596041
Publication date: 7 February 2001
Published in: Statistical Science (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1214/ss/1177011934
Related Items (11)
Some topics of current interest in clinical trials ⋮ Comment: is response-adaptive randomization a ``good thing or not in clinical trials? Why we cannot take sides ⋮ Clinician preferences and the estimation of causal treatment differences. (With comments) ⋮ Sequential procedures for comparing several medical treatments ⋮ Analyzing longitudinal count data from adaptive clinical trials: a weighted generalized quasi-likelihood approach ⋮ Social surveys and social science ⋮ Adaptive designs for binary treatment responses in phase III clinical trials: controversies and progress ⋮ Ethics, data-dependent designs, and the strategy of clinical trials: time to start learning-as-we-go? ⋮ Ethical issues in oncology biostatistics ⋮ A General Multi-Treatment Adaptive Design for Multivariate Responses ⋮ A class of adaptive designs
This page was built for publication: Ethics and statistics in randomized clinical trials. With comments and a rejoinder by the author